Aptar数字健康与阿斯利康合作,授权用于慢性肾病检测的人工智能算法相关的帖子:Aptar Digital Health Partners with AstraZeneca to License AI Algorithms for Chronic Kidney Disease Detection Related posts:

动脉网
26 May

by Mark Chiang由马克·蒋Share To分享到Aptar Digital Health has entered into a licensing agreement with AstraZeneca to utilize the pharmaceutical company’s artificial intelligence (AI) algorithms for detecting...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10